Literature DB >> 19795126

[Renal pelvic carcinoma: a different urothelial tumor?].

F Hofstädter1.   

Abstract

Urothelial tumors of the renal pelvis and the ureter do not differ from those of the urinary bladder concerning histopathological phenotypes. However, with respect to tumor biology there are relevant differences between the two tumor locations. The originating tissue (urothelium) of the bladder and of the upper urinary tract varies significantly with respect to developmental origin, morphology and physiological function. Specific pathways of tumorigenesis (e.g. hereditary non-polyposis colorectal cancer, HNPCC) and tumor propagation (seeding) are described for tumors of the upper urinary tract. Clinical epidemiological data indicate specific correlations between the two tumor locations.

Entities:  

Mesh:

Year:  2009        PMID: 19795126     DOI: 10.1007/s00292-009-1220-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  14 in total

Review 1.  [Molecular changes in development and progression of urothelial carcinoma].

Authors:  A Hartmann
Journal:  Verh Dtsch Ges Pathol       Date:  2003

2.  Changes in the urine composition during its passage through the ureter. A concept of urothelial function.

Authors:  Ahmed Shafik; Ismail Shafik; Olfat El Sibai; Ali A Shafik
Journal:  Urol Res       Date:  2005-11-13

3.  Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.

Authors:  C Hafner; R Knuechel; L Zanardo; W Dietmaier; H Blaszyk; J Cheville; F Hofstaedter; A Hartmann
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

4.  Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome.

Authors:  Sten Holmäng; Sonny L Johansson
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

5.  Does the composition of voided urine reflect that of the renal pelvis?

Authors:  Ahmed Shafik; Ismail Ahmed; Olfat El Sibai; Ali A Shafik
Journal:  Urol Res       Date:  2006-05-05

6.  Upper tract tumors in patients with primary bladder cancer followed for 15 years.

Authors:  H W Herr; M S Cookson; S M Soloway
Journal:  J Urol       Date:  1996-10       Impact factor: 7.450

7.  Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

Authors:  James W F Catto; Abdel-Rahmene Azzouzi; Ishtiaq Rehman; Kenneth M Feeley; Simon S Cross; Najla Amira; Gaelle Fromont; Mathilde Sibony; Oliver Cussenot; Mark Meuth; Freddie C Hamdy
Journal:  J Clin Oncol       Date:  2005-03-07       Impact factor: 44.544

8.  Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.

Authors:  Jonathan L Wright; James Hotaling; Michael P Porter
Journal:  J Urol       Date:  2009-01-16       Impact factor: 7.450

9.  Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.

Authors:  R H Sijmons; L A Kiemeney; J A Witjes; H F Vasen
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

10.  Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.

Authors:  Tao Chen; Lei Guo; Lu Zhang; Leming Shi; Hong Fang; Yongming Sun; James C Fuscoe; Nan Mei
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.